|
ZNF397OS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.68609999985048E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.94570000003436E-06 |
| Normal-vs-Stage2 |
1.178970E-03 |
| Normal-vs-Stage3 |
2.06439999539398E-08 |
| Normal-vs-Stage4 |
4.35170000001595E-06 |
| Stage1-vs-Stage2 |
7.335600E-01 |
| Stage1-vs-Stage3 |
5.898400E-02 |
| Stage1-vs-Stage4 |
2.430000E-01 |
| Stage2-vs-Stage3 |
1.020590E-01 |
| Stage2-vs-Stage4 |
2.312800E-01 |
| Stage3-vs-Stage4 |
8.142200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.04259999966771E-07 |
| Normal-vs-AfricanAmerican |
1.830410E-02 |
| Normal-vs-Asian |
3.987800E-04 |
| Caucasian-vs-AfricanAmerican |
3.244400E-01 |
| Caucasian-vs-Asian |
4.136600E-01 |
| AfricanAmerican-vs-Asian |
7.143600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.08530000000274E-05 |
| Normal-vs-Female |
4.29440000226933E-08 |
| Male-vs-Female |
3.341400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.58091999999943E-05 |
| Normal-vs-Age(41-60Yrs) |
1.28600000004475E-06 |
| Normal-vs-Age(61-80Yrs) |
1.87630000003658E-06 |
| Normal-vs-Age(81-100Yrs) |
1.744260E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.842400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.148000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.402800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.360400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.744800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.917800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.442820E-03 |
| Classical-VS-Follicular |
8.971400E-01 |
| Classical-VS-Other |
9.696000E-01 |
| Classical-VS-Normal |
2.06189999996109E-06 |
| Tall-VS-Follicular |
2.702100E-03 |
| Tall-VS-Other |
8.683700E-02 |
| Tall-VS-Normal |
2.84409995554569E-09 |
| Follicular-VS-Other |
9.429600E-01 |
| Follicular-VS-Normal |
3.825000E-04 |
| Other-VS-Normal |
9.850400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78070000000918E-06 |
| Normal-vs-N1 |
9.60410000000467E-05 |
| N0-vs-N1 |
6.774400E-01 |
|
|
